Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Adenosine Phosphate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 known ✓ | P47900 | 9/20 | 0.83 |
| ▸ | P2RY2 known ✓ | P41231 | 3/20 | 0.83 |
| ▸ | ADORA1 known ✓ | P30542 | 1/20 | 0.83 |
| ▸ | PDE4D known ✓ | Q08499 | 1/20 | 0.83 |
| ▸ | PDE3A known ✓ | Q14432 | 1/20 | 0.83 |
| ▸ | P2RY11 | Q96G91 | 3/20 | 0.83 |
| ▸ | SRC | P12931 | 2/20 | 0.83 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.83 |
| ▸ | TRPM2 | O94759 | 2/20 | 0.83 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.83 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.83 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.83 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.83 |
| ▸ | LDHA | P00338 | 1/20 | 0.83 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.83 |
| ▸ | FBP1 | P09467 | 1/20 | 0.83 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.83 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.83 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.83 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.83 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenosine Phosphate SCHEMBL145417 | 1.00 | P2RY1 (0.83) | P2RY1P2RY11P2RY2SRCSMN1; SMN2 | |
| Adenosine Phosphate SCHEMBL29364783 | 1.00 | P2RY1 (0.83) | P2RY1P2RY11P2RY2SRCSMN1; SMN2 | |
| Adenosine Phosphate SCHEMBL1356934 | 1.00 | P2RY1 (0.83) | P2RY1P2RY11P2RY2SRCSMN1; SMN2 | |
| Adenosine Phosphate SCHEMBL5600449 | 0.99 | P2RY1 (0.81) | P2RY1P2RY11P2RY2SRCSMN1; SMN2 | |
| Adenosine Phosphate SCHEMBL1164224 | 0.99 | P2RY1 (0.81) | P2RY1P2RY11P2RY2SRCSMN1; SMN2 | |
| Adenosine Phosphate SCHEMBL23093554 | 0.99 | P2RY1 (0.81) | P2RY1P2RY11P2RY2SRCSMN1; SMN2 | |
| Adenosine Phosphate SCHEMBL7064977 | 0.99 | P2RY1 (0.81) | P2RY1P2RY11P2RY2SRCSMN1; SMN2 | |
| Adenosine Phosphate SCHEMBL9068130 | 0.99 | P2RY1 (0.81) | P2RY1P2RY11P2RY2SRCSMN1; SMN2 | |
| Adenosine Phosphate SCHEMBL1164292 | 0.99 | P2RY1 (0.81) | P2RY1P2RY11P2RY2SRCSMN1; SMN2 | |
| Adenosine Phosphate SCHEMBL5434021 | 0.99 | P2RY1 (0.81) | P2RY1P2RY11P2RY2SRCSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1425 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075514-A | Use of glycogen phosphatase B agonists for the treatment of neurodegenerative diseases | — | 2026-05-26 | — | — | CN | claimed |
| CN-115595624-B | Catalyst for electrocatalytic hydrogenation of cinnamaldehyde and preparation method thereof | 天津大学 | 2024-06-04 | — | — | CN | claimed |
| CN-117551344-B | Low-moisture-absorption nylon material and preparation method thereof | 苏州优利金新材料有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-117551344-A | Low-moisture-absorption nylon material and preparation method thereof | 苏州优利金新材料有限公司 | 2024-02-13 | — | — | CN | claimed |
| US-20240041078-A1 | METHODS AND COMPOSITIONS FOR IMPROVED TASTE QUALITY | ALMENDRA PTE LTD (SG) | 2024-02-08 | — | — | US | claimed |
| WO-2023234116-A1 | SKIN TREATMENT DEVICE, OPERATION METHOD FOR OPERATING SKIN TREATMENT DEVICE, SKIN TREATMENT METHOD AND PROGRAM | ヤーマン株式会社 | 2023-12-07 | — | — | WO | claimed |
| EP-4282282-A2 | METHODS AND COMPOSITIONS FOR IMPROVED TASTE QUALITY | Almendra Pte. Ltd. (SG) | 2023-11-29 | — | — | EP | claimed |
| CN-111057746-B | Creatine kinase isoenzyme determination kit | 浙江夸克生物科技有限公司 | 2023-10-27 | — | — | CN | claimed |
| EP-4009810-B1 | METHODS AND COMPOSITIONS FOR IMPROVED TASTE QUALITY | ALMENDRA PTE LTD (SG) | 2023-06-21 | — | — | EP | claimed |
| CN-116133639-A | Formulations and methods for treating inflammatory diseases | 维奥梅治疗公司 | 2023-05-16 | — | — | CN | claimed |
| CN-1628691-A | Adenosine triphosphate salt composition and preparation method thereof | LIU XIAOQING (CN) | 2005-06-22 | — | — | CN | claimed |
| US-6583258-B1 | Transesterification catalyst is a salt of adenosine 5'-monophosphate or 2-deoxy-6-phosphogluconic acid; diaryl carbonate with a dihydroxy aromatic compound; bisphenol A with diphenyl carbonate | GENERAL ELECTRIC COMPANY | 2003-06-24 | — | — | US | claimed |
| US-6255291-B1 | MIXTURE OF ALANINE, ADENOSINE COMPOUND, RIBOSE COMPOUND, ASCORBIC ACID AND NICOTINIC ACID | PEREGRINE PHARMACEUTICALS, INC. | 2001-07-03 | — | — | US | claimed |
| US-6071888-A | COMPRISING A RIBOSE COMPOUND, L-BETA-ALANINE, ASCORBIC ACID, AND NICOTINIC ACID; USEFUL FOR TREATING MELANOMA | ALIATROS MEDICAL, A.S. (CZ) | 2000-06-06 | — | — | US | claimed |
| EP-0877617-A1 | COMPOSITION FOR TREATING CANCER CONTAINING A RIBOSE COMPOUND, BETA-ALANINE, ASCORBIC ACID AND NICOTINIC ACID | ALIATROS MEDICAL A.S. (CZ) | 1998-11-18 | — | — | EP | claimed |
| US-5665802-A | REACTING POLYAMIC ACID WITH A DEHYDRATION-CYCLIZATION AGENT, A CATALYST AND AN ORGANIC PHOSPHORUS COMPOUND; EXCELLENT IN TENSILE STRENGTH AND FLEXIBILITY | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1997-09-09 | — | — | US | claimed |
| WO-1997026893-A1 | COMPOSITION FOR TREATING CANCER CONTAINING A RIBOSE COMPOUND, BETA-ALANINE, ASCORBIC ACID AND NICOTINIC ACID | ALIATROS MEDICAL, A.S. (CZ) | 1997-07-31 | — | — | WO | claimed |
| US-4844884-A | TYROSINE DERIVATIVES AND ADENOSINE-5'-PHOSPHATES | INDUCHEM AG (CH) | 1989-07-04 | — | — | US | claimed |
| US-4544559-A | Nucleotide enriched humanized milk and process for its preparation | UNION INDUSTRIAL Y AGROGANADERA, S.A. (UNIASA) (ES) | 1985-10-01 | — | — | US | claimed |
| US-4067775-A | Process and composition for determining the activity of creatinekinase-MB | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1978-01-10 | — | — | US | claimed |